Skip to main navigation Skip to search Skip to main content

Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5α-reductase inhibitor

  • Debra M. Sutkowski
  • , James E. Audia
  • , Robin L. Goode
  • , Kenneth C. Hsiao
  • , Ilan Y. Leibovitch
  • , Ann M. McNulty
  • , Blake Lee Neubauer*
    • *Corresponding author for this work
  • Eli Lilly
  • Indiana University-Purdue University Indianapolis

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5α-reductase inhibitor'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology